what happens if you stop taking glp-1 Medications Infographic What Happens When You Stop

For patients with type 2 diabetes and ASCVD, starting a GLP-1 RA carries a Class 1, Level of Evidence A recommendation in the most recent ESC and ACC guidelines

Consistency is key with any hyperpigmentation treatment , so make it part of your regular routine rather than an occasional treat

Its unique pharmacokinetic properties, including predominantly non-renal elimination, make it suitable for patients with renal and hepatic impairments without dose adjustment

Effects of GLP-1RA on Kidney Outcomes in CKD Studies The FLOW-CKD trial examined the benefits of semaglutide compared to a placebo in patients with diabetes and CKD, specifically focusing on long-term kidney outcomes (Table 2)